|
MAGT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68349999996042E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.477670E-03 |
| Normal-vs-Stage2 |
1.438820E-01 |
| Normal-vs-Stage3 |
3.56540000000516E-05 |
| Normal-vs-Stage4 |
1.52176999999032E-05 |
| Stage1-vs-Stage2 |
8.654600E-01 |
| Stage1-vs-Stage3 |
2.502200E-02 |
| Stage1-vs-Stage4 |
1.190170E-02 |
| Stage2-vs-Stage3 |
1.152050E-01 |
| Stage2-vs-Stage4 |
8.207900E-02 |
| Stage3-vs-Stage4 |
9.935400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12189999999612E-05 |
| Normal-vs-AfricanAmerican |
1.08269999965493E-07 |
| Normal-vs-Asian |
7.336400E-01 |
| Caucasian-vs-AfricanAmerican |
8.459900E-03 |
| Caucasian-vs-Asian |
5.933400E-01 |
| AfricanAmerican-vs-Asian |
3.083400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.76689999987457E-07 |
| Normal-vs-Female |
1.835070E-03 |
| Male-vs-Female |
2.281800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.637300E-04 |
| Normal-vs-Age(41-60Yrs) |
5.164900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.88895999999605E-05 |
| Normal-vs-Age(81-100Yrs) |
8.171900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.777800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.718400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.797800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.633400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.011400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.952000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.019000E-01 |
| Normal-vs-Grade 2 |
4.163800E-02 |
| Normal-vs-Grade 3 |
1.96430000043435E-08 |
| Normal-vs-Grade 4 |
2.97359999956726E-07 |
| Grade 1-vs-Grade 2 |
3.073200E-01 |
| Grade 1-vs-Grade 3 |
6.779400E-03 |
| Grade 1-vs-Grade 4 |
4.781300E-03 |
| Grade 2-vs-Grade 3 |
2.604500E-03 |
| Grade 2-vs-Grade 4 |
1.355310E-03 |
| Grade 3-vs-Grade 4 |
1.325170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.057560E-01 |
| Normal-vs-ccB subtype |
2.30359999999763E-05 |
| ccA subtype-vs-ccB subtype |
3.735400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.035600E-04 |
| Normal-vs-N1 |
3.489600E-02 |
| N0-vs-N1 |
3.600200E-01 |
|
|
